Welcome to the Waldenstrom’s Macroglobulinemia Foundation of Canada (WMFC)

If you have been diagnosed with Waldenstrom’s Macroglobulinemia (WM) or care for someone who has, welcome to the WMFC family of WM patients, caregivers, friends and relatives. We are a community providing support, research and information on WM.

Sign up for our newsletter below to receive updated information.

Information for the newly diagnosed

BeiGene Announces Acceptance and Priority Review by Health Canada of New Drug Submission for BRUKINSA® (zanubrutinib) in Waldenström’s Macroglobulinemia

September 10, 2020CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that its New Drug Submission (NDS) Read More

Watchful Waiting Urged for Indolent Lymphoma During COVID-19

September 10, 2020Read Article

Waldenström Macroglobulinemia – 2020 Update on Management and Future Directions – Clinical Lymphoma, Myeloma and Leukemia

September 10, 2020Clinical Lymphoma, Myeloma, Leukemia Introduction Waldenström Macroglobulinemia (WM) is a low-grade B-cell lymphoproliferative disorder characterized by bone marrow infiltration with lymphoplasmacytic cells, together with an immunoglobulin M (IgM) monoclonal gammopathy. Read More

• 1
• 2
• 3

We have been compiling a list of websites that contain useful information about WM and also some information about the COVID-19 virus.